BeyondSpring (BYSI) Non-Current Debt (2019 - 2021)
BeyondSpring (BYSI) posted Non-Current Debt of $635000.0 for Q1 2021, down 70.7% sequentially from $2.2 million in Q4 2020, and down 55.06% YoY from $1.4 million in Q1 2020.
BeyondSpring (BYSI) Non-Current Debt (2019 - 2021) Analysis & Trends
BeyondSpring has reported Non-Current Debt for 3 years, with the latest figure at $635000.0 in Q1 2021.
- Quarterly Non-Current Debt fell 55.06% year-over-year to $635000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $635000.0 (down 55.06% YoY) and the FY2020 annual result came in at $2.2 million, up 50.91% from the prior year.
- Non-Current Debt fell to $635000.0 in Q1 2021 per BYSI's latest filing, from $2.2 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $3.0 million in Q1 2019 and troughed at $635000.0 in Q1 2021.
- A 3-year average of $1.9 million and a median of $2.0 million in 2020 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2020 and 2021: Non-Current Debt surged 50.91% in 2020, then plunged 55.06% in 2021.
- Over 3 years, Non-Current Debt stood at $1.4 million in 2019, then jumped by 50.91% to $2.2 million in 2020, then plunged by 70.7% to $635000.0 in 2021.
- According to Business Quant data, Non-Current Debt over the past three periods registered $635000.0, $2.2 million, and $2.1 million for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 635,000.00 |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.11 Mn |
| Jun 30, 2020 | 2.05 Mn |
| Mar 31, 2020 | 1.41 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Sep 30, 2019 | 1.40 Mn |
| Jun 30, 2019 | 2.91 Mn |
| Mar 31, 2019 | 2.98 Mn |